Understanding tolerance is crucial for the development of effective cancer therapies. Many current treatments aim to break this tolerance and enable the immune system to recognize and attack cancer cells. For example, checkpoint inhibitors are drugs that block proteins used by cancer cells to suppress the immune response, thereby lifting the tolerance and allowing T-cells to attack cancer.
